Loading...

Brilliant Violet 570™ anti-human CD8a Antibody

Pricing & Availability
Clone
RPA-T8 (See other available formats)
Regulatory Status
RUO
Workshop
IV T171
Other Names
T8, Leu2
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
RPA-T8_BV570_1_072611
Human peripheral blood lymphocytes were stained with CD3 and CD8 (clone RPA-T8) Brilliant Violet 570™ (top) or mouse IgG1, κ Brilliant Violet 570™ isotype control (bottom).
  • RPA-T8_BV570_1_072611
    Human peripheral blood lymphocytes were stained with CD3 and CD8 (clone RPA-T8) Brilliant Violet 570™ (top) or mouse IgG1, κ Brilliant Violet 570™ isotype control (bottom).
  • RPA-T8_BV570_2_072611
  • RPA-T8_CD8vCD56_072911
See Brilliant Violet 570™ spectral data
Cat # Size Price Save
301037 25 tests ¥37,210
301038 100 tests ¥91,960
Description

CD8a is a 32-34 kD type I glycoprotein. It forms a homodimer (CD8a/a) or heterodimer (CD8a/b) with CD8b. CD8, also known as T8 and Leu2, is a member of the immunoglobulin superfamily found on the majority of thymocytes, a subset of peripheral blood T cells, and NK cells (which express almost exclusively CD8a homodimers). CD8 acts as a co-receptor with MHC class I-restricted T cell receptors in antigen recognition and T cell activation, and has been shown to play a role in thymic differentiation. Two domains in CD8a are important for function: the extracellular IgSF domain binds the α3 domain of MHC class I and the cytoplasmic CXCP motif binds the tyrosine kinase p56 Lck.

Product Details
Technical data sheet

Product Details

Reactivity
Human,Cynomolgus,Rhesus
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 570™ under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Brilliant Violet 570™ excites at 405 nm and emits at 570 nm. The bandpass filter 585/42 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 570™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

The RPA-T8 antibody does not block the binding of HIT8a antibody to CD8a. Additional reported applications of this antibody (for the relevant formats) include: immunohistochemical staining of paraformaldehyde-fixed frozen sections3 and costimulation of T cell responses4. This clone was tested in-house and does not work on formalin fixed paraffin-embedded (FFPE) tissue. The Ultra-LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 301073 & 301074).

Application References

(PubMed link indicates BioLegend citation)
  1. Knapp W, et al. Eds. 1989. Leucocyte Typing IV. Oxford University Press. New York.
  2. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  3. Mack CL, et al. 2004. Pediatr. Res. 56:79. (IHC)
  4. Magidovich E, et al. 2007. P. Natl. Acad. Sci. USA 104:13022.
  5. Thakarl D, et al. 2008.J. immunol. 180:7431. PubMed
  6. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  7. Thakral D, et al. 2008. J. Immunol. 180:7431. (FC) PubMed
  8. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  9. Rout N, et al. 2010. PLoS One 5:e9787. (FC)
  10. Stoeckius M, et al. 2017. Nat. Methods. 14:865. (PG)
Product Citations
  1. Bradley T et al. 2018. Cell. 175(2):387-399 . PubMed
  2. Shifrut E et al. 2018. Cell. 175(7):1958-1971 . PubMed
  3. Darrah PA, et al. 2019. NPJ Vaccines. 4:21. PubMed
  4. Marquardt N, et al. 2019. Nat Commun. 10:3841. PubMed
  5. Escudero–Pérez B, et al. 2019. JCI Insight. 4:e126070. PubMed
  6. de Andrade LF, et al. 2019. JCI Insight. 4:e133103. PubMed
  7. Bradley T, et al. 2020. Nat Commun. 11:948. PubMed
  8. Han Q, et al. 2020. Cell Rep. 30:1553. PubMed
  9. Nishimura Y, et al. 2017. Nature. 543:559. PubMed
  10. Vierboom MPM, et al. 2020. NPJ Vaccines. 5:39. PubMed
  11. Blasi M, et al. 2020. NPJ Vaccines. 5:36. PubMed
  12. Tran TM, et al. 2020. Immunity. 51(4):750-765. PubMed
  13. Kang HM, et al. 2018. Nat Biotechnol. 36:89. PubMed
  14. Mawa P, et al. 2015. Phil Trans R Soc B. 19:370. PubMed
  15. Leeansyah E, et al. 2015. PLoS Pathog. 11: 1005072. PubMed
  16. García-Arriaza J, et al. 2015. J Virol. 89: 8525-8539. PubMed
  17. Bolton D, et al. 2016. J Virol. 90: 1321 - 1332. PubMed
  18. Swanstrom A, et al. 2016. J Virol. 90: 4966 - 4980. PubMed
  19. Hensley-McBain T, et al. 2016. J Virol. 90: 4981 - 4989. PubMed
  20. Paquin-Proulx D, et al. 2016. J Immunol. 197: 1843 - 1851. PubMed
  21. Negri D, et al. 2016. Mol Ther. 24:2021-2032. PubMed
  22. Roberts E, et al. 2016. PLoS One. 11:e0168488. PubMed
  23. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  24. Buggert M, et al. 2020. Cell. 183(7):1946-1961.e15. PubMed
  25. Maleki KT, et al. 2021. Cell Reports Medicine. 2(3):100220. PubMed
  26. Mold JE, et al. 2021. Cell Reports. 35(8):109174. PubMed
  27. Tauzin A, et al. 2021. Cell Host Microbe. . PubMed
  28. Vierboom MPM, et al. 2020. NPJ Vaccines. 5:39. PubMed
  29. Blasi M, et al. 2020. NPJ Vaccines. 5:36. PubMed
  30. Kaustio M, et al. 2021. J Allergy Clin Immunol. 148:599. PubMed
  31. Baier FA, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:745. PubMed
  32. Turner JS, et al. 2021. Nature. 596:109. PubMed
  33. King HAD, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  34. Veenhuis RT, et al. 2021. JCI Insight. 6:. PubMed
  35. Romero-Olmedo AJ, et al. 2022. Nat Microbiol. 7:195. PubMed
  36. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  37. Gagne M, et al. 2022. Cell. 185:113. PubMed
  38. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  39. Liechti T, et al. 2022. Nat Commun. 13:7255. PubMed
  40. Jebbawi F, et al. 2021. Parasite Immunol. 43:e12834. PubMed
  41. Nayrac M, et al. 2022. Cell Rep. 39:111013. PubMed
  42. Wu VH, et al. 2023. Nat Immunol. 24:359. PubMed
  43. Nicolas A, et al. 2023. iScience. 26:105904. PubMed
  44. Johnston SC, et al. 2022. Vaccines (Basel). 10:. PubMed
  45. Kroll KW, et al. 2022. Cell Rep Med. 3:100773. PubMed
  46. Sannier G, et al. 2023. Cell Rep Med. 4:100955. PubMed
  47. Preglej T, et al. 2023. Front Immunol. 14:1096096. PubMed
RRID
AB_10933259 (BioLegend Cat. No. 301037)
AB_2563213 (BioLegend Cat. No. 301038)

Antigen Details

Structure
Ig superfamily, homodimer or heterodimer with CD8β, 32-34 kD
Distribution

Majority of thymocytes, T cell subset, NK cells

Function
MHC class I co-receptor, thymic differentiation, T cell activation
Ligand/Receptor
MHC Class I molecules
Cell Type
Dendritic cells, NK cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay N, et al. 1993. The Leucocyte Antigen FactsBook. Academic Press Inc. San Diego.

Gene ID
925 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 07/13/2015

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account